BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Show more
FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company developing innovative...
- Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC...
FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company focused on developing...
The SEED-Eisai Research Collaboration leverages Eisaiβs leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -11.3924050633 | 2.37 | 2.54 | 2.05 | 18645 | 2.19196265 | CS |
4 | 0.14 | 7.14285714286 | 1.96 | 2.54 | 1.86 | 26985 | 2.09095887 | CS |
12 | -0.29 | -12.1338912134 | 2.39 | 2.6 | 1.695 | 24895 | 2.10425722 | CS |
26 | -1.02 | -32.6923076923 | 3.12 | 3.75 | 1.695 | 54093 | 2.5882626 | CS |
52 | 1.3407 | 176.570525484 | 0.7593 | 4 | 0.6534 | 97294 | 2.25762304 | CS |
156 | -13.2 | -86.2745098039 | 15.3 | 17.98 | 0.542 | 386672 | 4.61655328 | CS |
260 | -15.27 | -87.9101899827 | 17.37 | 33 | 0.542 | 458517 | 13.1889665 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.